Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial

Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page’s versioning information.
    Difference
    0.0%
    Check dated 2026-03-18T18:13:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3 on the Study Details page.
    Difference
    0.0%
    Check dated 2026-03-11T16:31:37.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, along with a banner about government funding; these changes affect only site metadata and banners, not the study details.
    Difference
    0.3%
    Check dated 2026-02-11T02:06:35.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    An administrative notice about government funding and NIH operations status was added, and the revision label changed to v3.4.1 (v3.4.0 removed), which appears cosmetic and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T00:01:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Show glossary now appears on the page; QC-related labels have been reformatted (Last Update Submitted that Met QC Criteria) and No FEAR Act Data capitalization adjusted. Revision updated from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-27T20:55:32.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added detailed Locations sections for numerous US states (California, Colorado, Illinois, Iowa, Kansas, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas) and international sites (Victoria, Emilia-Romagna, Lombardy) and updated the revision to v3.3.3. Removed the previous location lists (v3.3.2 reference) and updated the revision accordingly.
    Difference
    1%
    Check dated 2025-12-22T22:20:03.000Z thumbnail image

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.